Cited by 362Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 110 of the 113 references it cites were found in a registry or an index.

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Moran, Lisa, Teede, Helena·2009·Human Reproduction Update

DOI 10.1093/humupd/dmp008

Open this paper in CoChat — free account

Abstract

BACKGROUND Polycystic ovary syndrome (PCOS) is a common condition in women of reproductive age with well established metabolic abnormalities. There are numerous diagnostic criteria generating several reproductive diagnostic phenotypes [National Institute of Health (NIH) hyperandrogenic anovulatory PCOS and non-NIH PCOS including hyperandrogenic ovulatory or non-hyperandrogenic anovulatory PCOS]. There is ongoing debate regarding the optimal diagnostic criteria for PCOS and on the metabolic implications of newer non-NIH PCOS phenotypes. METHODS We reviewed the literature on the presence of risk factors for type 2 diabetes (DM2) and cardiovascular disease (CVD) across the reproductive diagnostic phenotypes of PCOS with the aims of comparing the metabolic features of the NIH and non-NIH groups and identifying potential high metabolic risk phenotypes of PCOS. RESULTS NIH PCOS patients present with greater obesity, abdominal obesity, insulin resistance (IR) and risk factors for DM2 and CVD compared with non-NIH ovulatory and non-hyperandrogenic PCOS patients. Where differences in metabolic features exist between the phenotypes, they are generally related to the degree of total and abdominal obesity. There is emerging evidence suggesting ovulatory and non-hyperandrogenic PCOS have greater metabolic abnormalities than controls primarily linked to abdominal adiposity. There is currently no evidence that non-hyperandrogenic PCOS is associated with a less adverse metabolic profile than ovulatory PCOS. CONCLUSIONS Current metabolic evidence appears to justify the inclusion of both non-NIH PCOS groups (ovulatory and non-hyperandrogenic) as PCOS subgroups. NIH PCOS is associated with a more adverse metabolic profile including greater total and abdominal obesity, IR and risk factors for CVD and DM2 than non-NIH phenotypes.

Integrity signals

Registry

Crossref · 10.1093/humupd/dmp008

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743

Flagged first, then by citations

Show all 113 references

3 of the 113 references couldn’t be matched to a known paper.

Sorted by citations

Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Self-citation
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Impaired Glucose Tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Self-citation
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Self-citation
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Self-citation
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Self-citation
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria
Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
Dewailly, D., Gronier, H., Poncelet, É., Robin, G., Leroy, M., Pigny, P., Duhamel, A., & Catteau-Jonard, S. (2011) · Human Reproduction · doi:10.1093/humrep/der297 · Cited by 483
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence
Qiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Self-citation
Dysbiosis of Gut Microbiota [DOGMA]—A novel theory for the development of Polycystic Ovarian Syndrome
Tremellen, K., & Pearce, K. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.016 · Cited by 359
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis
Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297
Lifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292
Self-citation
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Gnanadass, S. A., Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 305
Exercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267
Self-citation
Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome
Li, R., Brereton, R. E., Anderson, R. A., Wallace, A. M., & Ho, C. K. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.002 · Cited by 266
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Metabolic risk in PCOS: Phenotype and adiposity impact
Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.12.003 · Cited by 245
Self-citation
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
Hart, R. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00023.2015 · Cited by 247
Should all women with PCOS be treated for insulin resistance?
Marshall, J. C., & Dunaif, A. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 224
Polycystic ovary syndrome as a metabolic disease
Helvacı, N., & Yıldız, B. O. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 230
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
Rubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01354 · Cited by 195
The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance
Johnstone, E. B., Rosen, M. P., Neril, R., Trevithick, D., Sternfeld, B., Murphy, R. C., Addauan-Andersen, C., McConnell, D. S., Pera, R. A. R., & Cedars, M. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0202 · Cited by 200
The management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
Effects of Exercise on Insulin Resistance and Body Composition in Overweight and Obese Women with and without Polycystic Ovary Syndrome
Hutchison, S. K., Stepto, N. K., Harrison, C. L., Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0828 · Cited by 192
Self-citation
Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20‐year retrospective cohort study
Mani, H., Levy, M. J., Davies, M. J., Morris, D. H., Gray, L. J., Bankart, J., Blackledge, H., Khunti, K. K., & Howlett, T. A. (2012) · Clinical Endocrinology · doi:10.1111/cen.12068 · Cited by 192
Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews
Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J., & Moran, L. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13828 · Cited by 166
Self-citation
Ovarian Function and Obesity—Interrelationship, Impact on Women’s Reproductive Lifespan and Treatment Options
Rachoń, D., & Teede, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.026 · Cited by 161
Self-citation
The metabolic syndrome - an ongoing story.
Duvnjak, L. S., & Duvnjak, M. (2009) · PubMed · Cited by 157
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
Dewailly, D., Pigny, P., Soudan, B., Catteau-Jonard, S., Decanter, C., Poncelet, É., & Duhamel, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0334 · Cited by 155
Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome
Zhang, R., Liu, H., Bai, H., Zhang, Y., Liu, Q., Guan, L., & Fan, P. (2016) · Clinical Endocrinology · doi:10.1111/cen.13171 · Cited by 139
Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies
Fernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137
Self-citation
Renaming PCOS—A Two-State Solution
Dunaif, A. E., & Fauser, B. C. J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2040 · Cited by 134
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 133
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)
Hart, R. J., Doherty, D. A., Norman, R. J., Franks, S., Dickinson, J. E., Hickey, M., & Sloboda, D. M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.002 · Cited by 128
Physical activity and mental health in women with Polycystic Ovary Syndrome
Banting, L. K., Gibson-Helm, M., Polman, R., Teede, H. J., & Stepto, N. K. (2014) · BMC Women's Health · doi:10.1186/1472-6874-14-51 · Cited by 121
Self-citation
Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances
Spritzer, P. M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003051 · Cited by 118
The Role of Physical Activity in Preconception, Pregnancy and Postpartum Health
Brown, W. J., Hayman, M., Moran, L., Redman, L. M., & Harrison, C. L. (2016) · Seminars in Reproductive Medicine · doi:10.1055/s-0036-1583530 · Cited by 131
Self-citation
Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life
Pinola, P., Puukka, K., Piltonen, T. T., Puurunen, J., Vanky, E., Sundström-Poromaa, I., Stener-Victorin, E., Lindén Hirschberg, A., Ravn, P., Skovsager Andersen, M., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.017 · Cited by 113
Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study
Ollila, M., Arffman, R. K., Korhonen, E., Morin-Papunen, L. C., Franks, S., Junttila, J. M., & Piltonen, T. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad077 · Cited by 110
Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis
Zhu, S., Zhang, B., Jiang, X., Li, Z., Zhao, S., Cui, L., & Chen, Z.-J. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.013 · Cited by 109
Polycystic Ovary Syndrome: Definitions, Phenotypes and Diagnostic Approach
Livadas, S., & Diamanti‐Kandarakis, E. (2012) · Frontiers of hormone research · doi:10.1159/000341673 · Cited by 112
Nonhuman primate models of polycystic ovary syndrome
Abbott, D. H., Nicol, L. E., Levine, J. E., Xu, N., Goodarzi, M. O., & Dumesic, D. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.013 · Cited by 111
Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes
Wiltgen, D., & Spritzer, P. M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.015 · Cited by 105
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS
Zhang, J., Fan, P., Liu, H., Bai, H., Wang, Y., & Zhang, F. (2012) · Human Reproduction · doi:10.1093/humrep/des191 · Cited by 98
Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS
Fan, P., Liu, H., Wang, Y., Zhang, F., & Bai, H. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.10.010 · Cited by 90
The impact of obesity on oocytes: evidence for lipotoxicity mechanisms
Wu, L., Norman, R. J., & Robker, R. L. (2011) · Reproduction Fertility and Development · doi:10.1071/rd11904 · Cited by 90
The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta‐analysis
Behboudi‐Gandevani, S., Amiri, M., Yarandi, R. B., Noroozzadeh, M., Farahmand, M., Dovom, M. R., & Tehrani, F. R. (2017) · Clinical Endocrinology · doi:10.1111/cen.13477 · Cited by 89
Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization
Sterling, L., Liu, J., Okun, N. B., Sakhuja, A., Sierra, S., & Greenblatt, E. M. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.019 · Cited by 89
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
Józkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 96
Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in south-west Chinese women
Wang, Y., Liu, H., Fan, P., Bai, H., Zhang, J., & Zhang, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0986 · Cited by 86
Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome
Moran, L., Deeks, A. A., Gibson‐Helm, M. E., & Teede, H. J. (2012) · Human Reproduction · doi:10.1093/humrep/des114 · Cited by 86
Self-citation
MicroRNA-145 Negatively Regulates Cell Proliferation Through Targeting IRS1 in Isolated Ovarian Granulosa Cells From Patients With Polycystic Ovary Syndrome
Cai, G., Ma, X., Chen, B., Huang, Y., Liu, S., Yang, H., & Zou, W. (2016) · Reproductive Sciences · doi:10.1177/1933719116673197 · Cited by 85
Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome
Chang, A. Y., Lalia, A. Z., Jenkins, G. D., Dutta, T., Carter, R. E., Singh, R. J., & Nair, K. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.002 · Cited by 83
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome
Fraissinet, A., Robin, G., Pigny, P., Lefebvre, T., Catteau-Jonard, S., & Dewailly, D. (2017) · Human Reproduction · doi:10.1093/humrep/dex239 · Cited by 84
Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
Baldani, D. P., Škrgatić, L., & Ougouag, R. (2015) · International Journal of Endocrinology · doi:10.1155/2015/786362 · Cited by 85
A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Jamil, A. S., Alalaf, S., Al-Tawil, N. G., & Al‐Shawaf, T. (2015) · Reproductive Health · doi:10.1186/1742-4755-12-7 · Cited by 86
Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome
Mikaeili, S., Rashidi, B. H., Safa, M., Najafi, A., Sobhani, A., Asadi, E., & Abbasi, M. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4068-z · Cited by 79
Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes
Graff, S. K., Mário, F. M., Alves, B. C., & Spritzer, P. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.06.005 · Cited by 79
New biomarkers for diagnosis and management of polycystic ovary syndrome
Karakas, S. E. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.009 · Cited by 81
The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
Tehrani, F. R., Rashidi, H., Khomami, M. B., Tohidi, M., & Azizi, F. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-89 · Cited by 77
Polycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role?
Sobolewski, M., & Barrett, E. S. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371088 · Cited by 81
Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome
Zhang, H., Wang, W., Zhao, J., Jiao, P., Zeng, L., Zhang, H., Zhao, Y., Shi, L., Hu, H., Luo, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1085656 · Cited by 71
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B. G. A., & Hart, R. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565.pub2 · Cited by 68
Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study
Tehrani, F. R., Montazeri, S. A., Hosseinpanah, F., Cheraghi, L., Erfani, H., Tohidi, M., & Azizi, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137609 · Cited by 67
Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep
Cardoso, R. C., Veiga‐Lopez, A., Moeller, J., Beckett, E. M., Pease, A. P., Keller, E., Madrigal, V., Chazenbalk, G. D., Dumesic, D. A., & Padmanabhan, V. (2015) · Endocrinology · doi:10.1210/en.2015-1565 · Cited by 67
MicroRNAs related to androgen metabolism and polycystic ovary syndrome
Sørensen, A. E., Udesen, P. B., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.008 · Cited by 65
Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome
LENTSCHER, J. A., & DeCherney, A. H. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000563 · Cited by 73
Peripheral Blood Inflammatory-Immune Cells as a Predictor of Infertility in Women with Polycystic Ovary Syndrome
He, S., Mao, X., Lei, H., Dong, B., Guo, D., Zheng, B., & Sun, P. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s260770 · Cited by 65
Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
Sangaraju, S. L., Yepez, D., Grandes, X. A., Manjunatha, R. T., & Habib, S. (2022) · Cureus · doi:10.7759/cureus.25076 · Cited by 77
MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome
Glintborg, D., & Andersen, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0373 · Cited by 66
Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation
Mostinckx, L., Segers, I., Belva, F., Buyl, R., Santos‐Ribeiro, S., Blockeel, C., Smitz, J. E. J., Anckaert, E., Tournaye, H. J., & Vos, M. D. (2019) · Human Reproduction · doi:10.1093/humrep/dez086 · Cited by 59
AMH as part of the diagnostic PCOS workup in large epidemiological studies
Piltonen, T. T., Komsi, E., Morin-Papunen, L. C., Korhonen, E., Franks, S., Järvelin, M.-R., Arffman, R. K., & Ollila, M.-M. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad065 · Cited by 58
Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats
Tao, X., Cai, L., Chen, L., Ge, S., & Deng, X. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0555-8 · Cited by 60
MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome
Geng, Y., Sui, C., Xun, Y., Lai, Q., & Jin, L. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1335-x · Cited by 57
Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
de Medeiros, S. F., Yamamoto, M. M. W., de Medeiros, M. A. S., Barbosa, B. B., Soares, J. M., & Baracat, E. C. (2020) · Endocrine Connections · doi:10.1530/ec-19-0496 · Cited by 57
Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria
Alebić, M. Š., Bulum, T., Stojanović, N., & Duvnjak, L. S. (2014) · Endocrine · doi:10.1007/s12020-014-0182-5 · Cited by 56
Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome
Christ, J. P., Willis, A. D., Brooks, E. D., Brink, H. V., Jarrett, B. Y., Pierson, R. A., Chizen, D. R., & Lujan, M. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.001 · Cited by 54
Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes
Mumm, H., Jensen, D. M., Sørensen, J. A., Andersen, L. L. T., Ravn, P., Andersen, M., & Glintborg, D. (2014) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12545 · Cited by 54
The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population
Dargham, S. R., Ahmed, L., Kilpatrick, E. S., & Atkin, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181467 · Cited by 53
The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy
Spinedi, E., & Cardinali, D. P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1349868 · Cited by 52
Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats
Peng, Y., Guo, L., Gu, A., Shi, B., Ren, Y.-K., Cong, J., & Yang, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00198-8 · Cited by 50
Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls
Shishehgar, F., Ramezani Tehrani, F., Mirmiran, P., Hajian, S., Baghestani, A. R., & Moslehi, N. (2016) · Global Journal of Health Science · doi:10.5539/gjhs.v8n9p302 · Cited by 49
Follistatin and activins in polycystic ovary syndrome: Relationship to metabolic and hormonal markers
Teede, H. J., Ng, S., Hedger, M. P., & Moran, L. (2013) · Metabolism · doi:10.1016/j.metabol.2013.05.003 · Cited by 49
Self-citation
MiRNA-335-5p negatively regulates granulosa cell proliferation via SGK3 in PCOS
Yao, L., Li, M., Hu, J., Wang, W., & Gao, M. (2018) · Reproduction · doi:10.1530/rep-18-0229 · Cited by 50
Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.
(2013) · PubMed · doi:10.3275/9023 · Cited by 48
Self-citation
Insulin Resistance Is Not Strictly Associated with Energy Intake or Dietary Macronutrient Composition in Women with Polycystic Ovary Syndrome
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
Exercise Training in Polycystic Ovarian Syndrome Enhances Flow-Mediated Dilation in the Absence of Changes in Fatness
Sprung, V. S., Cuthbertson, D. J., Pugh, C. J. A., Aziz, N., Kemp, G. J., Daousi, C., GREEN, D. J., Cable, N. T., & Jones, H. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829ba9a1 · Cited by 46
Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
Behboudi‐Gandevani, S., Tehrani, F. R., Hosseinpanah, F., Khalili, D., Cheraghi, L., Kazemijaliseh, H., & Azizi, F. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.046 · Cited by 46

Authors: Moran, L., & Teede, H.
Affiliations: Jean Hailes (AU)
Corresponding author: Moran, Lisa
ORCID: Moran, Lisa
Teede, Helena
Venue: Human Reproduction Update
Publisher: Oxford University Press (OUP)
Published: 2009
Volume: 15
Issue: 4
Pages: 477-488
ISSN: 1355-4786 (ISSN-L)
1460-2369
DOI: 10.1093/humupd/dmp008
OpenAlex: W2102318195
Cited by: 362
References: 113
Citations by year: 2026: 10 · 2025: 15 · 2024: 11 · 2023: 20 · 2022: 18 · 2021: 28 · 2020: 23 · 2019: 19 · 2018: 21 · 2017: 18 · 2016: 25 · 2015: 23 · 2014: 25 · 2013: 30 · 2012: 21
FWCI: 3.58
Type: journal article
Language: en
Open access: closed
Locations: Human Reproduction Update (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, PCOS diagnostic criteria, metabolic abnormalities, insulin resistance, abdominal obesity, type 2 diabetes risk, cardiovascular risk
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks